FDA Clearance Tracker · P170011-S034
Impella RP
Last checked: Nov 20, 2026Latest source record: Nov 22, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Nov 22, 2021
Approved
Time to decision
137 days
Received Jul 8, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P170011-S034
- Device name
- Impella RP
- Applicant
- Abiomed, Inc.
- Applicant location
- Danvers, MA
- Received
- Jul 8, 2021
- Decided
- Nov 22, 2021
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P170011
Device type
- Device class
- Class III
- Regulation
- 21 CFR 870.4360
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for changes to the Impella pressure reservoir.
Source documents
Other decisions for Abiomed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252766 · Decided Oct 8, 2025 · 40 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
K241708 · Decided Aug 6, 2024 · 54 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
K221294 · Decided Jun 30, 2023 · 422 days after receipt
Device type: Catheter, Intravascular Occluding, Temporary (MJN) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.